Verona Pharma (VRNA) Earnings Date, Estimates & Call Transcripts $72.07 -1.14 (-1.56%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Verona Pharma Earnings Summary Latest Q1 Earnings DateApr. 29EstimatedConsensus EPS (Apr. 29) -$0.22 Actual EPS (Apr. 29) $0.27 Beat By $0.49 Actual Revenue (Apr. 29) $98.65MVerona Pharma announced Q1 2025 earnings on April 29, 2025, reporting an EPS of $0.27, which topped analysts' consensus estimates of -$0.22 by $0.49. Quarterly revenue was reported to be $98.65 million, above analyst estimates of $41.47 million. With a trailing EPS of -$2.16, Verona Pharma's earnings are expected to grow next year, from ($1.95) to $0.03 per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingPowered by Get Verona Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Verona Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRNA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Verona Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.24-$0.24-$0.24Q2 20251-$0.08-$0.08-$0.08Q3 20251$0.08$0.08$0.08Q4 20251$0.16$0.16$0.16FY 20254-$0.08-$0.08-$0.08Q1 20261$0.16$0.16$0.16Q2 20261$0.40$0.40$0.40 Verona Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025-$0.22$0.27+$0.49-$0.16$41.47M$98.65M11/4/2024Q3 2024-$0.44-$0.56 -$0.12-$0.56$2.31M$5.62M8/8/2024Q2 2024-$0.35-$0.88 -$0.53-$0.88--5/9/2024Q1 2024-$0.24-$0.32 -$0.08-$0.32--2/29/2024Q4 2023-$0.23-$0.16+$0.07-$0.16--11/2/2023Q3 2023-$0.27-$0.18+$0.09-$0.18--8/3/2023Q2 2023-$0.27-$0.11+$0.16-$0.11--5/9/2023Q1 2023-$0.22-$0.24 -$0.02-$0.24-- Verona Pharma Earnings - Frequently Asked Questions When did Verona Pharma announce their last quarterly earnings? Verona Pharma (NASDAQ:VRNA) last announced its quarterly earning data on Tuesday, April 29, 2025. Learn more on VRNA's earnings history. Did Verona Pharma beat their earnings estimates last quarter? In the previous quarter, Verona Pharma (NASDAQ:VRNA) reported $0.27 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.49. Learn more on analysts' earnings estimate vs. VRNA's actual earnings. How can I view Verona Pharma's earnings report? Verona Pharma's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Verona Pharma generate each year? Verona Pharma (NASDAQ:VRNA) has a recorded annual revenue of $42.28 million. How much profit does Verona Pharma generate each year? Verona Pharma (NASDAQ:VRNA) has a recorded net income of -$54.37 million. VRNA has generated -$2.16 earnings per share over the last four quarters. What is Verona Pharma's EPS forecast for next year? Verona Pharma's earnings are expected to grow from ($1.95) per share to $0.03 per share in the next year. More Earnings Resources from MarketBeat Related Companies SMMT Earnings Results TEVA Earnings Results ITCI Earnings Results GMAB Earnings Results RDY Earnings Results MRNA Earnings Results ASND Earnings Results VTRS Earnings Results QGEN Earnings Results ROIV Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of Earnings This page (NASDAQ:VRNA) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRNA Stock Free VRNA Stock Alerts